The severity of nearly all neuropathological diseases in AD, PD, and MS eventually leads to raised levels of TNF-α owing to enhanced glial cell production (Sharma et al., 2012; Sawada et al., 2006; Xu et al., 2015). This evidence concerns the gene TNF and Alzheimer disease.